MedTrace Logo

Study of the Effects of Pomegranate Tablets on Enlarged Prostates

NCT00381108 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-01-06

No results posted yet for this study

Summary

To determine whether pomegranate tablets have a therapeutic effect on Benign Prostatic Hyperplasia.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DRUG

Placebo Tablet

Two tablets, twice daily.

DRUG

Pomegranate Tablet

Two tablets, twice daily.

Sponsors & Collaborators

  • Pomegranate Health

    collaborator INDUSTRY

  • Jarrow Pharmaceuticals

    collaborator UNKNOWN

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Leland Ronningen, MD · UCIMC Department of Urology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00381108 on ClinicalTrials.gov